Regressive melanoma in a female patient: A case report.
metastasis
prognostic
regressive melanoma
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
18
12
2019
accepted:
17
01
2020
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
ppublish
Résumé
Regressive melanoma is a phenomenon characterized by partial or complete replacement of cutaneous melanoma by fibrotic structures as a result of local host immune response. The dermoscopic features include 'scar-like' depigmentation that can be described as hypopigmented to pigmented macules, pink macules, linear-irregular vessels, globular vessel pattern, hyperpigmented macular remnants, blue gray 'peppered' papular remnants and white transverse bands. Fully regressive melanoma is very rare, and, in majority of cases, the tumor is associated with metastases, so the prognosis is very poor due to this fact. Regressive melanomas are rare since it represents an advance stage of melanoma evolution. Their treatment requires a collaboration between the dermatologist and the oncologist in order to improve the quality of life of the patient and also the survival rate.
Identifiants
pubmed: 32508999
doi: 10.3892/etm.2020.8675
pii: ETM-0-0-8675
pmc: PMC7271722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
87-90Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
Rom J Intern Med. 2012 Apr-Jun;50(2):145-53
pubmed: 23326958
Int J Cancer. 1997 Oct 9;73(2):198-203
pubmed: 9335442
J Clin Aesthet Dermatol. 2016 Aug;9(8):42-6
pubmed: 27672418
PLoS One. 2016 May 23;11(5):e0156115
pubmed: 27213536
J Interferon Cytokine Res. 1999 Feb;19(2):171-7
pubmed: 10090402
Arch Dermatol. 2007 Jan;143(1):21-8
pubmed: 17224538
Oncol Lett. 2016 May;11(5):3354-3360
pubmed: 27123116
Am J Clin Pathol. 2005 Jul;124(1):37-48
pubmed: 15923172
Lab Invest. 2017 Feb 27;97(6):657-668
pubmed: 28240749
Mod Pathol. 2006 Feb;19 Suppl 2:S34-40
pubmed: 16446714
Rom J Morphol Embryol. 2013;54(1):51-62
pubmed: 23529309
Oncol Rep. 2017 Sep;38(3):1327-1340
pubmed: 28713981
Oncol Lett. 2019 May;17(5):4102-4111
pubmed: 30944603
Br J Dermatol. 2008 Jun;158(6):1224-9
pubmed: 18341656
J Natl Cancer Inst. 2001 Jul 18;93(14):1047-8
pubmed: 11459861
J Am Acad Dermatol. 2008 May;58(5 Suppl 2):S129-32
pubmed: 18410798
J Cutan Pathol. 2004 Jan;31(1):1-7
pubmed: 14675278
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
Oncol Rep. 2014 Mar;31(3):1079-82
pubmed: 24424406